IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000067 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
51,279
Total Value
$313,308.06
P&L
+inf% (+$1,767,651.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Development Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 11,119 | $0.00 | $0.00 | 18,859 | Direct | โ | View Details | |
EVP, Chief Development Officer | Common Stock | โ | Jan 16, 2026 | Sale | 4,141 | $75.66 | $313,308.06 | 14,718 | Direct | โ | View Details | |
EVP, Chief Development Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 11,119 | $0.00 | $0.00 | 20,830 | Direct | โ | View Details | |
EVP, Chief Development Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 13,650 | $0.00 | $0.00 | 34,480 | Direct | โ | View Details | |
EVP, Chief Development Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 11,250 | $0.00 | $0.00 | 45,730 | Direct | โ | View Details |